loading
Papers Papers/2022 Papers Papers/2022

Research.Publish.Connect.

Paper

Paper Unlock

Authors: Rendy Revandana Bramantya ; Iswan Abbas Nusi ; Poernomo Boedi Setiawan ; Herry Purbayu ; Titong Sugihartono ; Ummi Maimunah ; Ulfa Kholili ; Budi Widodo ; Amie Vidyani ; Muhammad Miftahussurur and Husin Thamrin

Affiliation: Department of Internal Medicine, Faculty of medicine Universitas Airlangga, Dr. Soetomo General Hospital and Surabaya, Indonesia

Keyword(s): Ulcerative colitis, inflammatory bowel disease, ulcerative colitis diagnosis, infection, immunosuppressant

Abstract: Ulcerative colitis is one part of inflammatory bowel disease and a chronic illness characterized by diffuse inflammation in the colonic mucosa. Ulcerative colitis is also influenced by lifestyle such as smoking, a diet high in sugar and fat, drug use, and stress. Genetic factors also have a role in ulcerative colitis. This study aimed to review the diagnosis and management of ulcerative colitis. The pathogenesis of inflammatory bowel disease is a result of continuous antigen stimulation by commensal enteric bacteria, fungi and viruses causing chronic inflammation in hosts with a genetic disorder and defects in mucosal barrier function as well as immunoregulation. The main clinical symptoms of ulcerative colitis are diarrhea with blood and mucus and abdominal pain. The diagnosis of ulcerative colitis is established based on typical clinical symptoms, stool examination, colonoscopy, and biopsy checks. These steps are performed to confirm the presence of colitis and to exclude infection . A typical endoscopic and histological outcome with negative outcomes from evaluation for infectious diseases will support the diagnosis of ulcerative colitis. Treatment of ulcerative colitis should be adjusted to the severity of the disease, divided into therapeutics for maintenance and therapy for remission. The goal of therapy is to induce and maintain remission conditions to improve patients’ quality of life, reduce long-term steroid requirements and minimize cancer risk. Patients' prognosis is generally quite good despite the often-deteriorating quality of life. (More)

CC BY-NC-ND 4.0

Sign In Guest: Register as new SciTePress user now for free.

Sign In SciTePress user: please login.

PDF ImageMy Papers

You are not signed in, therefore limits apply to your IP address 13.58.45.238

In the current month:
Recent papers: 100 available of 100 total
2+ years older papers: 200 available of 200 total

Paper citation in several formats:
Bramantya, R.; Nusi, I.; Setiawan, P.; Purbayu, H.; Sugihartono, T.; Maimunah, U.; Kholili, U.; Widodo, B.; Vidyani, A.; Miftahussurur, M. and Thamrin, H. (2018). Diagnosis and Management of Ulcerative Colitis. In Proceedings of Surabaya International Physiology Seminar - SIPS; ISBN 978-989-758-340-7; ISSN 2184-3678, SciTePress, pages 405-412. DOI: 10.5220/0007339804050412

@conference{sips18,
author={Rendy Revandana Bramantya. and Iswan Abbas Nusi. and Poernomo Boedi Setiawan. and Herry Purbayu. and Titong Sugihartono. and Ummi Maimunah. and Ulfa Kholili. and Budi Widodo. and Amie Vidyani. and Muhammad Miftahussurur. and Husin Thamrin.},
title={Diagnosis and Management of Ulcerative Colitis},
booktitle={Proceedings of Surabaya International Physiology Seminar - SIPS},
year={2018},
pages={405-412},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0007339804050412},
isbn={978-989-758-340-7},
issn={2184-3678},
}

TY - CONF

JO - Proceedings of Surabaya International Physiology Seminar - SIPS
TI - Diagnosis and Management of Ulcerative Colitis
SN - 978-989-758-340-7
IS - 2184-3678
AU - Bramantya, R.
AU - Nusi, I.
AU - Setiawan, P.
AU - Purbayu, H.
AU - Sugihartono, T.
AU - Maimunah, U.
AU - Kholili, U.
AU - Widodo, B.
AU - Vidyani, A.
AU - Miftahussurur, M.
AU - Thamrin, H.
PY - 2018
SP - 405
EP - 412
DO - 10.5220/0007339804050412
PB - SciTePress